Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Frontiers in Aging Neuroscience|November 17, 2022
Management of advanced Parkinson's disease in Israel: Clinicians viewpoint and action itemsTanya Gurevich, David Arkadir, Samih Badarny, et al.CNS Spectrums|September 11, 2018
Dysphagia characteristics in Huntington's disease patients: insights from the Fiberoptic Endoscopic Evaluation of Swallowing and the Swallowing Disturbances QuestionnaireYael Manor, Yael Oestreicher-Kedem, Alona Gad, et al.Transplantation|October 27, 2005
Nonmyeloablative conditioning does not prevent telomere shortening after allogeneic stem cell transplantationMeir Lahav, Orit Uziel, Meir Kestenbaum, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 2020
A Possible Modifying Effect of the G2019S Mutation in the LRRK2 Gene on GBA Parkinson's DiseaseNurit Omer, Nir Giladi, Tanya Gurevich, et al.Movement Disorders Clinical Practice|April 18, 2023
The Influence of GBA and LRRK2 on Mood Disorders in Parkinson's DiseaseJake DeBroff, Nurit Omer, Batsheva Cohen, et al.Journal of Neurology|January 3, 2021
Biochemical markers for severity and risk in GBA and LRRK2 Parkinson's diseaseAvner Thaler, Nurit Omer, Nir Giladi, et al.Scientific Reports|June 11, 2020
Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's diseaseAvner Thaler, Shani Shenhar-Tsarfaty, Yanay Shaked, et al.Journal of Parkinson'S Disease|May 17, 2021
Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory MarkersAvner Thaler, Nurit Omer, Nir Giladi, et al.Journal of Neurology|May 4, 2025
Intrathecal methotrexate in progressive multiple sclerosis: a phase 1 open-label study with long-term follow-upHadar Kolb, Yuval Shachaf, Karin Fainberg, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 22, 2021
Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or SeverityNurit Omer, Nir Giladi, Tanya Gurevich, et al.Pageof 3